Swiss Pharmaceuticals & Biotech Potentially Undervalued Companies

Sandoz Group

Market Cap: CHF 13.7b

Develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide.

Merck

Market Cap: CHF 199.2b

Operates as a healthcare company worldwide.

Teva Pharmaceutical Industries

Market Cap: CHF 18.6b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

Novartis

Market Cap: CHF 163.4b

Engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally.

Merck KGaA

Market Cap: CHF 50.1b

Operates as a science and technology company in Germany.

Gerresheimer

Market Cap: CHF 1.8b

Manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally.

Roche Holding

Market Cap: CHF 195.4b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

Bayer

Market Cap: CHF 19.3b

Operates as a life science company worldwide.

Bristol-Myers Squibb

Market Cap: CHF 100.3b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Joincare Pharmaceutical Group IndustryLtd

Market Cap: US$19.2b

Joincare Pharmaceutical Group Industry Co.,Ltd.

Cosmo Pharmaceuticals

Market Cap: CHF 741.5m

Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.

AstraZeneca

Market Cap: CHF 155.2b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

Tilray Brands

Market Cap: CHF 485.9m

A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally.

Newron Pharmaceuticals

Market Cap: CHF 120.4m

A biopharmaceutical company, focus on the discovery and development of novel therapies for the treatment of central nervous system (CNS) and pain in Italy and the United States.

PolyPeptide Group

Market Cap: CHF 481.1m

Operates as a contract development and manufacturing company in Europe, the United States, and India.

Novartis

Market Cap: CHF 163.4b

Engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally.

Jazz Pharmaceuticals

Market Cap: CHF 6.1b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

Xlife Sciences

Market Cap: CHF 111.4m

Focuses on the development and commercialization of technologies in the life sciences sector.

CRISPR Therapeutics

Market Cap: CHF 3.4b

A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.

Gilead Sciences

Market Cap: CHF 94.1b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Qiagen

Market Cap: CHF 9.2b

Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.

Roche Holding

Market Cap: CHF 195.4b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

Evotec

Market Cap: CHF 1.9b

Operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide.

Johnson & Johnson

Market Cap: CHF 365.6b

Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

Biogen

Market Cap: CHF 27.0b

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

Santhera Pharmaceuticals Holding

Market Cap: CHF 161.5m

A specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia.

Relief Therapeutics Holding

Market Cap: CHF 30.2m

A biopharmaceutical company, focuses on identification, development, and commercialization of novel, patent protected products for the treatment of rare metabolic, dermatological, and pulmonary diseases in Switzerland, Europe, North America, and internationally.

SKAN Group

Market Cap: CHF 1.4b

Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.

Galderma Group

Market Cap: CHF 18.1b

Operates as a dermatology company worldwide.

Amgen

Market Cap: CHF 145.8b

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

UCB

Market Cap: CHF 16.3b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.

Moderna

Market Cap: CHF 53.4b

A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

Basilea Pharmaceutica

Market Cap: CHF 478.5m

Engages in the discovering, developing, and commercializing drugs for bacterial or fungal infections.

Siegfried Holding

Market Cap: CHF 3.7b

Engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.

Eli Lilly

Market Cap: CHF 657.7b

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.

CSL

Market Cap: CHF 122.0b

Researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.